Concourse Financial Group Securities’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6437 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7078 |
|
|
2024
Q3 | – | Sell |
-3
| Closed | -$123 | – | 7074 |
|
|
2024
Q2 | $123 | Buy |
+3
| New | +$123 | ﹤0.01% | 2264 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7087 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7016 |
|
|
2023
Q3 | – | Sell |
-13
| Closed | -$599 | – | 6852 |
|
|
2023
Q2 | $599 | Buy |
+13
| New | +$599 | ﹤0.01% | 2204 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6450 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6458 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6283 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6230 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6115 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6076 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5899 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5703 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5515 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5364 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5154 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5020 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4985 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4923 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4729 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4857 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4785 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4677 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4450 |
|